Study finds network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainA simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive declin

Updated on: May 08,2024

Study finds network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainA simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive declin

Updated on:May 08,2024

Nearly a third of Americans use gray market caregivers to aid the elderly and those with dementia

by RAND CorporationCredit: CC0 Public DomainNearly a third of Americans who arranged for paid care for an older person or someone with dementia employed workers who were not hired through a regul

Updated on: July 01,2024

Nearly a third of Americans use gray market caregivers to aid the elderly and those with dementia

by RAND CorporationCredit: CC0 Public DomainNearly a third of Americans who arranged for paid care for an older person or someone with dementia employed workers who were not hired through a regul

Updated on:July 01,2024

How developing neurons build 'mini-computers' for increased computational power

by Netherlands Institute for Neuroscience - KNAWFigure dendritic domains. Credit: Netherlands Institute for NeuroscienceA new mouse study from the Netherlands Institute for Neuroscience (NIN) reveals

Updated on: July 31,2024

How developing neurons build 'mini-computers' for increased computational power

by Netherlands Institute for Neuroscience - KNAWFigure dendritic domains. Credit: Netherlands Institute for NeuroscienceA new mouse study from the Netherlands Institute for Neuroscience (NIN) reveals

Updated on:July 31,2024

P-glycoprotein removes Alzheimer's-associated toxin from the brain

by Southern Methodist University(A) The first frame of SMU's simulation shows amyloid-β bound to the drug binding domains of P-gp. (B) The final frame of the same simulation shows P-gp pushin

Updated on: April 01,2024

P-glycoprotein removes Alzheimer's-associated toxin from the brain

by Southern Methodist University(A) The first frame of SMU's simulation shows amyloid-β bound to the drug binding domains of P-gp. (B) The final frame of the same simulation shows P-gp pushin

Updated on:April 01,2024

New cases of dementia in the UK fall by 20 percent over two decades

by University of CambridgeThe UK has seen a 20% fall in the incidence of dementia over the past two decades, according to new research from England, led by the University of Cambridge, leading to

Updated on: February 28,2024

New cases of dementia in the UK fall by 20 percent over two decades

by University of CambridgeThe UK has seen a 20% fall in the incidence of dementia over the past two decades, according to new research from England, led by the University of Cambridge, leading to

Updated on:February 28,2024

Alzheimer's disease: How amyloid aggregates alter neuronal function

by CNRSRat hippocampal neurons in primary culture, showing a fluorescent soluble protein (left) and trajectories corresponding to the movement of the glutamate receptors on its surface, measured

Updated on: April 08,2024

Alzheimer's disease: How amyloid aggregates alter neuronal function

by CNRSRat hippocampal neurons in primary culture, showing a fluorescent soluble protein (left) and trajectories corresponding to the movement of the glutamate receptors on its surface, measured

Updated on:April 08,2024

FAU site for first US clinical trial for Lewy Body dementia

by Florida Atlantic UniversityThe South Florida clinical trial is directed by one of the world's leading neuroscientists and an expert on LBD, James E. Galvin, M.D., M.P.H., a professor of cl

Updated on: February 28,2024

FAU site for first US clinical trial for Lewy Body dementia

by Florida Atlantic UniversityThe South Florida clinical trial is directed by one of the world's leading neuroscientists and an expert on LBD, James E. Galvin, M.D., M.P.H., a professor of cl

Updated on:February 28,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024

Five things to know when a loved one is diagnosed with Alzheimer's

by University of Southern CaliforniaCredit: AI-generated imageSeeing the personality and whole being erased in loved ones with Alzheimer's disease can be a heart-wrenching experience.Mental h

Updated on: May 20,2024

Five things to know when a loved one is diagnosed with Alzheimer's

by University of Southern CaliforniaCredit: AI-generated imageSeeing the personality and whole being erased in loved ones with Alzheimer's disease can be a heart-wrenching experience.Mental h

Updated on:May 20,2024

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on: February 28,2024

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on:February 28,2024

Rosacea linked to a slightly increased risk of dementia

by WileyA new study has uncovered an increased risk of dementia—in particular Alzheimer's disease—in patients with rosacea. Importantly, the risk was highest in older patients and in patients

Updated on: February 28,2024

Rosacea linked to a slightly increased risk of dementia

by WileyA new study has uncovered an increased risk of dementia—in particular Alzheimer's disease—in patients with rosacea. Importantly, the risk was highest in older patients and in patients

Updated on:February 28,2024

Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

by Sarah C.p. Williams,Gladstone InstitutesA new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages o

Updated on: April 10,2024

Alzheimer's disease may cause vicious circle between brain network and immune cell dysfunctions

by Sarah C.p. Williams,Gladstone InstitutesA new study by Gladstone scientists suggests that certain anti-epileptic or tau-reducing treatments could be promising for people in the early stages o

Updated on:April 10,2024